Brainsway Ltd

NASDAQ:BWAY USA Medical Devices
Market Cap
$538.53 Million
Market Cap Rank
#14384 Global
#5789 in USA
Share Price
$13.73
Change (1 day)
+0.59%
52-Week Range
$7.86 - $26.04
All Time High
$26.04
About

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, sc… Read more

Brainsway Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.95%

Brainsway Ltd (BWAY) has an Asset Resilience Ratio of 0.95% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$1.08 Million
Cash + Short-term Investments
Total Assets
$113.06 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how Brainsway Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Brainsway Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $1.08 Million 0.95%
Total Liquid Assets $1.08 Million 0.95%

Asset Resilience Insights

  • Limited Liquidity: Brainsway Ltd maintains only 0.95% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Brainsway Ltd Industry Peers by Asset Resilience Ratio

Compare Brainsway Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220
Medical Devices 9.34%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%

Annual Asset Resilience Ratio for Brainsway Ltd (2012–2024)

The table below shows the annual Asset Resilience Ratio data for Brainsway Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.00% $0.00 $94.32 Million --
2023-12-31 56.32% $35.47 Million $62.97 Million +55.90pp
2022-12-31 0.42% $271.00K $64.48 Million -52.96pp
2021-12-31 53.38% $40.43 Million $75.73 Million +52.73pp
2020-12-31 0.65% $221.00K $34.01 Million +0.08pp
2019-12-31 0.57% $221.00K $38.74 Million +0.14pp
2018-12-31 0.43% $101.00K $23.60 Million +0.24pp
2017-12-31 0.18% $50.00K $27.03 Million -2.75pp
2016-12-31 2.93% $585.00K $19.96 Million +0.30pp
2015-12-31 2.63% $585.00K $22.24 Million -1.56pp
2014-12-31 4.19% $1.08 Million $25.77 Million -3.98pp
2013-12-31 8.16% $1.46 Million $17.85 Million -37.63pp
2012-12-31 45.80% $4.89 Million $10.69 Million --
pp = percentage points